Literature DB >> 17495413

Mechanistic analysis for drug permeation through intestinal membrane.

Masahiro Hayashi1, Mikio Tomita.   

Abstract

For drug absorption, intestinal drug permeability's through both the paracellular and transcellular routes were analyzed. Absorption enhancers, such as sodium caprate (C10), decanoylcarnitine (DC) and tartaric acid (TA), increased the paracellular permeability of water-soluble, low lipophilic and poorly absorbable drugs by enlargement of tight junction (TJ) adhering to the intercellular portion; that is, expansion of the paracellular routes. C10 increased the intracellular calcium level to induce contraction of calmodulin-dependent actin filaments. Although DC also increased the intracellular calcium level, the action was independent of calmodulin, and thus the action mechanism of DC was considered to differ from that of C10. DC and TA decreased the intracellular ATP level and the intracellular pH, suggesting that intracellular acidosis increases the calcium level through decrease in ATP level followed by opening TJ. TA had no effect on Western blot analysis, but TA significantly inhibited excretion of rhodamine 123, one of the P-glycoprotein (P-gp) substrates, from the serosal to mucosal side, suggesting that TA increases the intestinal absorption of P-gp substrates, possibly by inhibiting the P-gp function without changing the expression of P-gp. During ischemia/reperfusion (I/R) injury during small intestine grafting, TJ opening and decrease in P-gp function simultaneously occurred. The in vitro model of I/R showed that lipid peroxidation is a trigger of the injury, and superoxide and iron ion participate in TJ opening and decrease in P-gp function. Colonic epithelial cells have the specific transcellular transport systems for lipopolysaccharide (LPS), one of which shows substrate specificity in the interaction with CD14 and/or that of TLR4. In the infective disease induced by LPS, the mucosal LPS sensitive transport capability was decreased and in the secretory direction, the receptor-mediated uptake mechanism disappeared. LPS taken up into the cells can be excreted by P-gp or mrp. The expression levels and function of the secretory transporters were considered to be increased in the infective condition. In conclusion, changes in TJ as the membrane structure and P-gp as the membrane function are important factors controlling intestinal membrane transport.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17495413     DOI: 10.2133/dmpk.22.67

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  8 in total

1.  Effects of combining low frequency ultrasound irradiation with papaverine on the permeability of the blood-tumor barrier.

Authors:  Jing-e Wang; Yun-hui Liu; Li-bo Liu; Chun-yi Xia; Zhen Zhang; Yi-xue Xue
Journal:  J Neurooncol       Date:  2010-08-04       Impact factor: 4.130

2.  P-glycoprotein regulates blood-testis barrier dynamics via its effects on the occludin/zonula occludens 1 (ZO-1) protein complex mediated by focal adhesion kinase (FAK).

Authors:  Linlin Su; Dolores D Mruk; Wing-Yee Lui; Will M Lee; C Yan Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

3.  Pharmacokinetics of paracetamol in Göttingen minipigs: in vivo studies and modeling to elucidate physiological determinants of absorption.

Authors:  Claudia Suenderhauf; Gerald Tuffin; Helle Lorentsen; Hans-Peter Grimm; Christophe Flament; Neil Parrott
Journal:  Pharm Res       Date:  2014-05-03       Impact factor: 4.200

4.  Application of activated nucleoside analogs for the treatment of drug-resistant tumors by oral delivery of nanogel-drug conjugates.

Authors:  Thulani H Senanayake; Galya Warren; Xin Wei; Serguei V Vinogradov
Journal:  J Control Release       Date:  2013-02-04       Impact factor: 9.776

5.  The enhanced intestinal permeability of infant mice enables oral protein and macromolecular absorption without delivery technology.

Authors:  John P Gleeson; Katherine C Fein; Namit Chaudhary; Rose Doerfler; Alexandra N Newby; Kathryn A Whitehead
Journal:  Int J Pharm       Date:  2020-11-26       Impact factor: 5.875

Review 6.  Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy.

Authors:  Alberto J Espay; Fernando L Pagan; Benjamin L Walter; John C Morgan; Lawrence W Elmer; Cheryl H Waters; Pinky Agarwal; Rohit Dhall; William G Ondo; Kevin J Klos; Dee E Silver
Journal:  Neurol Clin Pract       Date:  2017-02

Review 7.  Interactions of Gut Microbiota, Endotoxemia, Immune Function, and Diet in Exertional Heatstroke.

Authors:  Lawrence E Armstrong; Elaine C Lee; Elizabeth M Armstrong
Journal:  J Sports Med (Hindawi Publ Corp)       Date:  2018-04-16

8.  A novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms.

Authors:  Shmuel Tuvia; Dori Pelled; Karen Marom; Paul Salama; Maya Levin-Arama; Irina Karmeli; Gregory H Idelson; Isaac Landau; Roni Mamluk
Journal:  Pharm Res       Date:  2014-02-21       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.